JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB183939

Anti-NMDAR2A antibody [EPR19694]

Be the first to review this product! Submit a review

|

(2 Publications)

Rabbit Recombinant Monoclonal NMDAR2A antibody. Suitable for WB and reacts with Mouse, Rat samples. Cited in 2 publications.

View Alternative Names

GluN2A, Glutamate [NMDA] receptor subunit epsilon-1, N-methyl D-aspartate receptor subtype 2A, NMDAR2A, NR2A, Grin2a

2 Images
Western blot - Anti-NMDAR2A antibody [EPR19694] (AB183939)
  • WB

Supplier Data

Western blot - Anti-NMDAR2A antibody [EPR19694] (AB183939)

Blocking/Dilution buffer : 5% NFDM/TBST.

Exposure times : Lane 1 : 3 minutes; Lane 2 : 30 seconds; Lane 3, 4, 5, 6 and 7 : 3 minutes.

NMDAR2A has been previously documented to be specifically expressed in neuron cells. (PMID : 12127670).

All lanes:

Western blot - Anti-NMDAR2A antibody [EPR19694] (ab183939) at 1/1000 dilution

Lane 1:

Mouse hippocampus lysate at 20 µg

Lane 2:

Rat hippocampus lysate at 20 µg

Lane 3:

Mouse brain lysate at 20 µg

Lane 4:

Rat brain lysate at 20 µg

Lane 5:

Mouse heart lysate at 20 µg

Lane 6:

Rat kidney lysate at 20 µg

Lane 7:

Mouse spleen lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Predicted band size: 165 kDa

Observed band size: 165 kDa

false

Western blot - Anti-NMDAR2A antibody [EPR19694] (AB183939)
  • WB

Supplier Data

Western blot - Anti-NMDAR2A antibody [EPR19694] (AB183939)

Blocking/Dilution buffer : 5% NFDM/TBST.

Exposure times : Lane 1 : 1 seconds; Lane 2 : 3 minutes.

All lanes:

Western blot - Anti-NMDAR2A antibody [EPR19694] (ab183939) at 1/5000 dilution

Lane 1:

His-tagged mouse NMDAR2A recombinant protein fragment (aa aa22-326) at 0.01 µg

Lane 2:

His-tagged mouse NMDAR2B recombinant protein fragment (aa27-322) at 0.01 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Predicted band size: 165 kDa

Observed band size: 165 kDa

false

  • Carrier free

    Anti-NMDAR2A antibody [EPR19694] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR19694

Isotype

IgG

Carrier free

No

Reacts with

Mouse, Rat

Applications

WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

style
left-column

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICC" : {"fullname" : "Immunocytochemistry", "shortname":"ICC"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Mouse": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "ICC-species-checked": "notRecommended", "ICC-species-dilution-info": "", "ICC-species-notes": "<p></p>" }, "Rat": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "ICC-species-checked": "notRecommended", "ICC-species-dilution-info": "", "ICC-species-notes": "" } } }
style
left-column

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

style
left-column

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle
style
left-column

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

NMDAR2A also known as GRIN2A is a subunit of the N-methyl-D-aspartate (NMDA) receptor which belongs to the family of ionotropic glutamate receptors. This receptor functions as a ligand-gated ion channel and requires both glutamate and glycine for activation. NMDAR2A has a molecular mass of about 164 kDa. It plays a significant role in synaptic transmission and plasticity and is mainly expressed in the brain particularly in the cerebral cortex and hippocampus. Its expression is important for normal brain function affecting learning and memory.
Biological function summary

NMDAR2A participates in synaptic signaling by forming part of the NMDA receptor complex. As part of this complex NMDAR2A interacts with other receptor subunits such as NR1 and NR2B which together modulate calcium influx into the neuron. This influx is essential for activating downstream signaling pathways that influence synaptic strength. The receptor's activation is tightly regulated which helps to maintain the balance between synaptic excitation and inhibition in the central nervous system.

Pathways

NMDAR2A serves essential roles in the long-term potentiation (LTP) and synaptic plasticity pathways. LTP is a process that strengthens synaptic connections and is important for memory formation. NMDAR2A interacts with proteins like postsynaptic density protein 95 (PSD-95) within these pathways to mediate downstream signaling events. It is also involved in the MAPK/ERK pathway affecting cellular processes such as gene expression differentiation and survival.

NMDAR2A has been associated with epilepsy and schizophrenia. Mutations or altered expression of NMDAR2A can disrupt normal receptor function and contribute to these conditions. It shows links with other proteins such as NR2B where imbalances between different NMDA receptor subunits may exacerbate disease pathology. Understanding how NMDAR2A functions and misfunctions helps in investigating therapeutic targets for these neurological diseases.
style
left-column
style
left-column

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:
style
left-column

Target data

Component of N-methyl-D-aspartate (NMDA) receptors (NMDARs) that function as heterotetrameric, ligand-gated cation channels with high calcium permeability and voltage-dependent block by Mg(2+) (PubMed : 12008020, PubMed : 1374164). NMDARs participate in synaptic plasticity for learning and memory formation by contributing to the slow phase of excitatory postsynaptic current, long-term synaptic potentiation, and learning (PubMed : 7816096, PubMed : 8987814). Channel activation requires binding of the neurotransmitter L-glutamate to the GluN2 subunit, glycine or D-serine binding to the GluN1 subunit, plus membrane depolarization to eliminate channel inhibition by Mg(2+) (PubMed : 12008020, PubMed : 1374164, PubMed : 7790891). NMDARs mediate simultaneously the potasium efflux and the influx of calcium and sodium (By similarity). Each GluN2 subunit confers differential attributes to channel properties, including activation, deactivation and desensitization kinetics, pH sensitivity, Ca2(+) permeability, and binding to allosteric modulators (PubMed : 10436042, PubMed : 12008020). Participates in the synaptic plasticity regulation through activation by the L-glutamate releaseed by BEST1, into the synaptic cleft, upon F2R/PAR-1 activation in astrocyte (PubMed : 25645137).
See full target information Grin2a
style
left-column

Publications (2)

Recent publications for all applications. Explore the full list and refine your search

The European journal of neuroscience 55:18-31 PubMed34902209

2021

Hippocampal AMPA- and NMDA-induced cGMP signals are mainly generated by NO-GC2 and are under tight control by PDEs 1 and 2.

Applications

Unspecified application

Species

Unspecified reactive species

Jan Giesen,Evanthia Mergia,Doris Koesling,Michael Russwurm

Frontiers in oncology 9:1545 PubMed32039020

2020

Changes in Tumor-Infiltrating Lymphocytes and Vascular Normalization in Breast Cancer Patients After Neoadjuvant Chemotherapy and Their Correlations With DFS.

Applications

Unspecified application

Species

Unspecified reactive species

Qiong Wang,Qun Xiang,Lan Yu,Ting Hu,Yangyang Chen,Jue Wang,Xiu Nie,Jing Cheng
View all publications
style
left-column
style
left-column
style
right-column

Alternative Products

Primary Antibodies

AB169873

Anti-NMDAR2A antibody

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-NMDAR2A antibody (AB169873)

  • 0
  • 0
Primary Antibodies

AB227233

Anti-NMDAR2A antibody - N-terminal

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-NMDAR2A antibody - N-terminal (AB227233)

  • 0
  • 0
Primary Antibodies

AB240884

Anti-NMDAR2A antibody [S327-95] - N-terminal

Immunocytochemistry/ Immunofluorescence - Anti-NMDAR2A antibody [S327-95] - N-terminal (AB240884)

  • 0
  • 1
Primary Antibodies

AB174636

Anti-NMDAR2A antibody [N327A/38] - N-terminal

Immunocytochemistry/ Immunofluorescence - Anti-NMDAR2A antibody [N327A/38] - N-terminal (AB174636)

  • 1
  • 1
Primary Antibodies

AB203197

Anti-NMDAR2A antibody

Immunocytochemistry/ Immunofluorescence - Anti-NMDAR2A antibody (AB203197)

  • 3
  • 2
Primary Antibodies

AB133265

Anti-NMDAR2A antibody [EPR7063]

20ul selling size|RabMAb|Recombinant

Western blot - Anti-NMDAR2A antibody [EPR7063] (AB133265)

  • 0
  • 0
Primary Antibodies

AB124913

Anti-NMDAR2A antibody [EPR2465(2)]

20ul selling size|RabMAb|Recombinant

Western blot - Anti-NMDAR2A antibody [EPR2465(2)] (AB124913)

  • 0
  • 0
Primary Antibodies

AB106590

Anti-NMDAR2A (phospho Y1325) antibody

Western blot - Anti-NMDAR2A (phospho Y1325) antibody (AB106590)

  • 3
  • 1
Primary Antibodies

AB232332

Anti-NMDAR2A antibody [EPR2465(2)] - BSA and Azide free

RabMAb|Recombinant

Western blot - Anti-NMDAR2A antibody [EPR2465(2)] - BSA and Azide free (AB232332)

  • 0
  • 0

Complementary Products

Primary Antibodies

AB65783

Anti-NMDAR2B antibody

Western blot - Anti-NMDAR2B antibody (AB65783)

  • 4
  • 5
Primary Antibodies

AB109182

Anti-NMDAR1 antibody [EPR2481(2)] - Neuronal Marker

20ul selling size|KO Validated|RabMAb|Recombinant

Immunocytochemistry/ Immunofluorescence - Anti-NMDAR1 antibody [EPR2481(2)] - Neuronal Marker (AB109182)

  • 4
  • 4
Secondary Antibodies

AB150077

Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488)

Immunocytochemistry/ Immunofluorescence - Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (AB150077)

  • 5
  • 20
Primary Antibodies

AB109450

Anti-Glutamate Receptor 1 (AMPA subtype) antibody [EPR5479]

RabMAb|Recombinant

Immunoprecipitation - Anti-Glutamate Receptor 1 (AMPA subtype) antibody [EPR5479] (AB109450)

  • 5
  • 2

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com